MEEDER ASSET MANAGEMENT INC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 37 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q2 2018. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$2,000
+100.0%
1,494
+98.9%
0.00%–
Q1 2019$1,000
-83.3%
751
-70.8%
0.00%
-100.0%
Q4 2018$6,0000.0%2,572
+163.8%
0.00%–
Q3 2018$6,000
-99.9%
975
+299.6%
0.00%–
Q2 2018$5,751,000–244–0.00%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q2 2018
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders